tm
Seeing Is Believing
tm
Seeing Is Believing
IMNM is currently covered by 2 analysts with an average price target of $25.04. This is a potential upside of $10.77 (75.47%) from yesterday's end of day stock price of $14.27.
Immunome 's activity chart (see below) currently has 2 price targets and 6 ratings on display. The stock rating distribution of IMNM is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 109.25 days.
Highest price target for IMNM is $33, Lowest price target is $33, average price target is $25.04.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 01-Apr-2024. First documented stock forecast 20-Aug-2021.
Currently out of the existing stock ratings of IMNM, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
33
$18.73 (131.25%)
19
25 days ago
2/3 (66.67%)
$10.89 (49.25%)
14
Buy
8
$-6.27 (-43.94%)
9
1 years 1 months 9 days ago
3/3 (100%)
$2.31 (40.60%)
398
Buy
33
$8.26 (33.39%)
35
2 years 3 months 15 days ago
0/2 (0%)
$21.36 (183.51%)
Buy
21
$12.65 (151.50%)
2 years 8 months 6 days ago
1/1 (100%)
$8.5 (68.00%)
25
What is IMNM (Immunome ) average time for price targets to be met?
Which analyst has the current highest performing score on IMNM (Immunome ) with a proven track record?
Which analyst has the current lower performing score on IMNM (Immunome ) with a proven track record?
Which analyst has the most public recommendations on IMNM (Immunome )?
Which analyst is the currently most bullish on IMNM (Immunome )?
Which analyst is the currently most reserved on IMNM (Immunome )?
